Test Bank for Pharmacotherapeutics for Advanced Practice, Fifth Edition (Arcangelo, 2021), Chapter 1-56 |All Chapters

FULL TEST b
b




TEST BANK FOR PHARMACOTHERAPEUTICS FORb b
b




b



ADVANCED PRACTICE A PRACTICAL APPROACH 5TH
b b b b b b



EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
b b b b b




PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
b b b b b b




PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
b b b b b b b b b




VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
b b b b b b b




['LIZ)LI12%5IL!


[LI.GIL


Complete Test bank, All Chapters are included.
b b b b b b




For more Test banks, ATI, HES! exams, and more contact us.
b b b b b b b b b b

, Tableofcontent b b




Chapter I Issues for the Practitioner in Drug Therapy
b b b b b b b b



Chapter 2 Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles
b b b b b b b b



Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics
b b b b b b b b b b b



Chapter 4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation
b b b b b b b b b b



Chapter 5 Pharmacotherapy Principles in Older Adults
b b b b b b b



Chapter 6 Principles of Antimicrobial Therapy
b b b b b



Chapter 7 Pharmacogenomies
b b b



Chapter 8 The Economics of Pharmacotherapeutics
b b b b b



Chapter 9 Pharmacotherapy of Pain Management
b b b b b b



Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients
b b b b b b b b b



Chapter 11 Cannabis and Pain Management
b b b b b b



Chapter 12 Contact Dermatitis
b b b



Chapter 13 Fungal, Viral, and Bacterial Infections of the Skin
b b b b b b b b b



Chapter 14 Psoriasis
b b b



Chapter I5 Acne Vulgaris and Rosacea
b b b b b



Chapter 16 Ophthalmic Disorders
b b b b



Chapter I7 Otitis Media and Otitis Externa
b b b b b b



Chapter I8 Hypertension
b b b



Chapter I9 Hyperlipidemia
b b



Chapter 20 Chronic Stable Angina and Myocardial Infarction
b b b b b b b



Chapter 2I Heart Failure
b b b b



Chapter 22 Arrhythmias
b b



Chapter 23 Respiratory Infections
b b b



Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease
b b b b b b b



Chapter 25 Gastric, Functional, and Inflammatory Bowel Disorders
b b b b b b b b



Chapter 26 Gastroesophageal Reflux Disease and Peptic Ulcer Disease
b b b b b b b b b



Chapter 27 Liver Diseases
b b b b



Chapter 28 Urinary Tract Infection
b b b b



Chapter 29 Prostatic Disorders and Erectile Dysfunction
b b b b b b



Chapter 30 Overactive Bladder
b b b b



Chapter 3I Sexually Transmitted Infections
b b b b



Chapter 32 Osteoarthritis and Gout
b b b b b



Chapter 33 Osteoporosis
b b b



Chapter 34 Rheumatoid Arthritis
b b b



Chapter 35 Headaches
b b b



Chapter 36 Seizure Disorders
b b b



Chapter 37 Alzheimer's Disease
b b b b



bChapter 38 Parkinson's
b b



Disease
b



Chapter 39 Major Depressive Disorder and Bipolar Disorders
b b b b b b b



Chapter 40 Anxiety Disorders
b b b b



Chapter 41 Sleep Disorders
b b b


Chapter 42 Attention Deficit Hyperactivity Disorder
b b b b b



Chapter 43 Substance Use Disorders
b b b b b



Chapter 44 Diabetes Mellitus
b b b



Chapter 45 Thyroid and Parathyroid Disorders
b b b b b

,Chapter 46 Allergies and Allergic Reactions
b b b b b



Chapter 47 Human Immunodeficiency Virus
b b b b b



Chapter 48 Organ Transplantation
b b b b



Chapter 49 Thromboembolic Disorders
b b b



Chapter 50 Anemias
b b b



Chapter 5l Immunizations
b b



Chapter 52 Smoking Cessation
b b b b



Chapter 53 Weight Loss
b b b b



Chapter 54 Contraception
b b b



Chapter 55 Menopause
b b



Chapter 56 Vaginitis
b b

, b



lOMoAR b cPSD| b 21007614




Chapter 1 Issues for the Practitioner in Drug Therapy
b b b b b b b b




MULTIPLE CHOICE b




1. Nurse practitioner prescriptive authority is regulated by:
b b b b b b


A. The National Council of State Boards of Nursing
b b b b b b b


B. The U.S. Drug Enforcement Administration
b b b b


C. The State Board of Nursing for each state
b b b b b b b


D. The State Board of Pharmacy
b b b b




ANS: C b PTS: 1 b




2. Physician Assistant (PA) prescriptive authority is regulated by:
b b b b b b b


A. The National Council of State Boards of Nursing
b b b b b b b


B. The U.S. Drug Enforcement Administration
b b b b


C. The State Board of Nursing
b b b b


D. The State Board of Medical Examiners
b b b b b




ANS: D b PTS: 1 b




3. Clinical judgment in prescribing includes:
b b b b


A. Factoring in the cost to the patient of the medication prescribed
b b b b b b b b b b


B. Always prescribing the newest medication available for the disease process
b b b b b b b b b


C. Handing out drug samples to poor patients
b b b b b b


D. Prescribing all generic medications to cut costsb b b b b b




ANS: A b PTS: 1 b




4. Criteria for choosing an effective drug for a disorder include:
b b b b b b b b b


A. Asking the patient what drug they think would work best for them
b b b b b b b b b b b


B. Consulting nationally recognized guidelines for disease management
b b b b b b


C. Prescribing medications that are available as samples before writing a prescription
b b b b b b b b b b


D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
b b b b b b b


prescribing
b




ANS: B b PTS: 1 b




5. Nurse practitioner practice may thrive under health-care reform due to:
b b b b b b b b b


A. The demonstrated ability of nurse practitioners to control costs and improve patient
b b b b b b b b b b b


outcomes
b


B. The fact that nurse practitioners will be able to practice independently
b b b b b b b b b b


C. The fact that nurse practitioners will have full reimbursement under health-care
b b b b b b b b b b


reform
b


D. The ability to shift accountability for Medicaid to the state level
b b b b b b b b b b




ANS: A b PTS: 1 b